Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays

Information

  • Patent Grant
  • 11121328
  • Patent Number
    11,121,328
  • Date Filed
    Tuesday, September 1, 2020
    4 years ago
  • Date Issued
    Tuesday, September 14, 2021
    3 years ago
Abstract
Platinum and palladium complexes are disclosed that can be useful as narrow band phosphorescent emitters. Also disclosed are methods for preparing and using the platinum and palladium complexes.
Description
BACKGROUND
Technical Field

The present disclosure relates to platinum and palladium complexes that can be useful as narrow band phosphorescent emitters in, for example, full color displays.


Technical Background

Compounds capable of absorbing and/or emitting light are ideally suited for use in a wide variety of applications, including optical and electro-optical devices, photo-absorbing devices, and as markers for bio-applications. Much research has been devoted to the discovery and optimization of organic and organometallic materials for use in such applications. Generally, research in this area aims to accomplish a number of goals, including improvements in absorption and emission efficiency, as well as improvements in processing ability, among others.


Despite significant advances in research devoted to optical, electro-optical, and marker materials, existing materials have a number disadvantages, including poor processing ability, inefficient emission or absorption, and less than ideal stability, among others. Thus, a need exists for new materials which exhibit improved performance in optical emitting and absorbing applications. This need and other needs are satisfied by the present invention.


SUMMARY

The present invention relates to platinum and palladium complexes that can be useful as narrow band phosphorescent emitters in, for example, full color displays. Such complexes are useful in organic-light-emitting-diodes (OLEDs).


Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.


In one aspect, the present invention provides a complex that can be represented by the general formula




embedded image



where (N{circumflex over ( )}C) represents the emitting portion of the ligand, (L{circumflex over ( )}X) represents an ancillary portion of the ligand, which may be linked, or not linked, M represents platinum or palladium, R represents a linking motif that connects (N{circumflex over ( )}C) to (L{circumflex over ( )}X) while disrupting the conjugation between them.


In one aspect, the excited state properties of the complex can be represented by the scheme:




embedded image



The energy of the ligand centered triplet state (3LC), and the metal-to-ligand charge transfer state (1MLCT) can be tuned independently. The nature of the emitting portion (N{circumflex over ( )}C) drive the emission energy, as well as the width of the emission profile. The nature of the ancillary portion (L{circumflex over ( )}X) is responsible for the enhancement or suppression of the vibronic progression in the emission profile, as well as the decay rates associated with emission. Control of both can yield complexes that emit narrowly at wavelengths useful for display applications.


In one aspect, the present invention provides a complex that can be represented by the formula:




embedded image



wherein M represents platinum, palladium, or a combination thereof, where each of Ar1, Ar2, and Ar3 independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; wherein each of X1, X2 and X3 can individually be coordinated to a platinum and/or palladium atom, and can independently represent a carbon or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, wherein Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; wherein W can be coordinated to a platinum or a palladium atom, and can be represented as a halogen atom, an aryl group, or a heteroaryl group which may be substituted bonded directly or through an oxygen atom, sulfur atom, nitrogen atom, or phosphorous atom; wherein A can represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein A can optionally be substituted, wherein each of b1, b2, and b3 can individually optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


In another aspect, the present invention provides a complex that can be represented by the formula:




embedded image



wherein M represents platinum, palladium, or a combination thereof, wherein each of Ar1, Ar2, Ar3, and Ar4 independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; where each of X1, X2, X3 and X4 can individually be coordinated to a platinum and/or palladium atom, and can independently represent a carbon and/or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, wherein Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; wherein each of A1 and A2 can independently represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein each of A1 and A2 can independently optionally be substituted, wherein each of b1 and b2 can individually optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


In still another aspect, the present invention provides a complex that can be represented by the formula:




embedded image



wherein M represents platinum, palladium, or a combination thereof, wherein each of Ar1, Ar2, Ar3, and Ar4 independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; wherein each of X1, X2, X3 and X4 can individually be coordinated to the platinum and/or palladium atom, and can independently represent a carbon and/or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, wherein Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; wherein A1 can represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein A1 can optionally be substituted, wherein each b1, b2, and b3 can individually optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


Also disclosed are full color display devices comprising one or more of the platinum complexes described herein.





BRIEF DESCRIPTION OF THE FIGURES

The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several aspects and together with the description serve to explain the principles of the invention.



FIG. 1 illustrates an emission spectra of the compound Pt-N1N (inset) at 77K and room temperature, in accordance with various aspects of the present disclosure.



FIG. 2 illustrates the room temperature emission spectra of the compounds Pt-N1N, Pt-N2N, and Pt-N3N(inset), in accordance with various aspects of the present disclosure.





Additional aspects of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or can be learned by practice of the invention. The advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.


DESCRIPTION

The present invention can be understood more readily by reference to the following detailed description of the invention and the Examples included therein.


Before the present compounds, devices, and/or methods are disclosed and described, it is to be understood that they are not limited to specific synthetic methods unless otherwise specified, or to particular reagents unless otherwise specified, as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, example methods and materials are now described.


The chemical names and structures disclosed herein can also comprise bonds stemming from those structures. For example, if




embedded image



is pyridine, then the bonds from the




embedded image



structure are included in the pyridine, thus, for example, X1 can be either the nitrogen or a carbon in the pyridine that is bonded to another component of the complex, for example the M component.


As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a component” includes mixtures of two or more components.


Ranges can be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. It is also understood that there are a number of values disclosed herein, and that each value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.


As used herein, the terms “optional” or “optionally” means that the subsequently described event or circumstance can or can not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.


The term “alkyl” as used herein is a branched or unbranched saturated hydrocarbon group of 1 to 24 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl group can be cyclic or acyclic. The alkyl group can be branched or unbranched. The alkyl group can also be substituted or unsubstituted. For example, the alkyl group can be substituted with one or more groups including, but not limited to, optionally substituted alkyl, cycloalkyl, alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, or thiol, as described herein. A “lower alkyl” group is an alkyl group containing from one to six (e.g., from one to four) carbon atoms.


The terms “amine” or “amino” as used herein are represented by the formula NA1A2A3, where A1, A2, and A3 can be, independently, hydrogen or optionally substituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.


The term “halide” as used herein refers to the halogens fluorine, chlorine, bromine, and iodine.


The term “hydroxyl” as used herein is represented by the formula —OH.


The term “nitro” as used herein is represented by the formula —NO2.


The term “nitrile” as used herein is represented by the formula —CN.


The term “thiol” as used herein is represented by the formula —SH.


Disclosed are the components to be used to prepare the compositions of the invention as well as the compositions themselves to be used within the methods disclosed herein. These and other materials are disclosed herein, and it is understood that when combinations, subsets, interactions, groups, etc. of these materials are disclosed that while specific reference of each various individual and collective combinations and permutation of these compounds can not be explicitly disclosed, each is specifically contemplated and described herein. For example, if a particular compound is disclosed and discussed and a number of modifications that can be made to a number of molecules including the compounds are discussed, specifically contemplated is each and every combination and permutation of the compound and the modifications that are possible unless specifically indicated to the contrary. Thus, if a class of molecules A, B, and C are disclosed as well as a class of molecules D, E, and F and an example of a combination molecule, A-D is disclosed, then even if each is not individually recited each is individually and collectively contemplated meaning combinations, A-E, A-F, B-D, B-E, B—F, C-D, C-E, and C—F are considered disclosed. Likewise, any subset or combination of these is also disclosed. Thus, for example, the sub-group of A-E, B-F, and C-E would be considered disclosed. This concept applies to all aspects of this application including, but not limited to, steps in methods of making and using the compositions of the invention. Thus, if there are a variety of additional steps that can be performed it is understood that each of these additional steps can be performed with any specific embodiment or combination of embodiments of the methods of the invention.


The term “heterocyclic” or the like terms refer to cyclic structures including a heteroatom. Thus, “heterocyclic” includes both aromatic and non-aromatic ring structures with one or more heteroatoms. Non-limiting examples of heterocyclic includes, pyridine, isoquinoline, methylpyrrole and thiophene etc.


As briefly described above, the present invention is directed to platinum and/or palladium complexes. In one aspect, the compositions disclosed here can provide emission spectra of platinum and/or palladium. In another aspect, the compositions disclosed herein can provide tunable emission spectra. In yet another aspect, the compositions disclosed herein can have an emission spectrum having a narrow bandwidth.


In one aspect, the inventive composition comprises a platinum (II) complex. In another aspect, the inventive composition comprises a palladium (II) complex.


For any of the structures recited herein, unless specifically stated to the contrary, various symbols and/or abbreviations are used wherein: M represents platinum, palladium, or a combination thereof, where each of Ar1, Ar2, Ar3, and Ar4, if present, independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; where each Xn can be coordinated to a platinum and/or palladium atom, and can independently represent a carbon and/or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, where Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; where each An can independently represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein each An can optionally be substituted, where each bn can optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


Also, for any of the structures recited herein, Rn can represent R1-R10, where each R can independently represent a hydrogen atom, an alkyl group, a haloalkyl group, an aralkyl group, an alkenyl group, an alkynyl group, an aryl group, an amino group, a mono- or di-alkylamino group, a mono- or diaryl amino group, an alkoxy group, an aryloxy group, a heteroaryloxy group, an alkoxycarbonyl group, an acyloxy group, an acylamino group, an alkoxycarbonylamino group, an aryloxycarbonylamino group, a sulfonylamino group, a sulfamoyl group, a carbamoyl group, an alkylthio group, a sulfinyl group, an ureido group, a phosphoramide group, a hydroxyl group, amercapto group, a halogen atom, a cyano group, a sulfo group, a carboxyl group, a nitro group, a hydrzino group, a substituted silyl group, a polymerizable group, or a combination thereof; wherein if a plurality of R's are present (e.g., Rn), n can be from about 0 to about 4, and wherein each R can be the same or different from any other R, and wherein U, if present, can be oxygen, sulfur, or N—Rn. Also, designation of R1, R2, R3 etc in the application relates to the definition of Rn. Thus, limited subset of R1, R2, R3 etc recited in the application does not preclude other substituents defined as Rn to also be included in that list.


In one aspect, the compositions of the present invention can be represented by the general formula:




embedded image



wherein M represents platinum, palladium, or a combination thereof, where each of Ar1, Ar2, and Ar3 independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; wherein each of X1, X2 and X3 can individually be coordinated to a platinum and/or palladium atom, and can independently represent a carbon or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, where Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; wherein W can be coordinated to a platinum or a palladium atom, and can be represented as a halogen atom, an aryl group, or a heteroaryl group which may be substituted bonded directly or through an oxygen atom, sulfur atom, nitrogen atom, or phosphorous atom; wherein A can represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein A can optionally be substituted, wherein each of b1, b2, and b3 can individually optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


In one aspect, M can be Pt, such as Pt(II). In another aspect, M can be Pd, such as Pd(II).


In one aspect, W can be Cl or F. For example, W can be Cl. In another aspect, W can be C3-C6 alkynyl. For example, W can be C3 alkynyl. In another aspect, W can be nitrile. In another aspect, W can be C6-C10 aryl. For example, W can be phenyl or naphthyl. The phenyl or naphthyl can be substituted or unsubstituted. For example, the phenyl can be unsubstituted. In another example, the phenyl can be alkyl substituted, such as C1-C6 alkyl substituted. In another aspect, the C6-C10 aryl can be bonded to M via an oxygen atom. In another aspect, W can be C5-C9 hetero aryl. For example, W can be isoquinoline. In another example, W can be quinazoline.


In one aspect,




embedded image



can be pyridine, quinazoline, isoquinoline, methylimidazole, or




embedded image


In one aspect,




embedded image



can be phenyl or pyridine.


In one aspect,




embedded image



can be phenyl or pyridine.


In one aspect,




embedded image



can be phenyl.


In one aspect,




embedded image



can be phenyl or can be absent. For example,




embedded image



can be absent. In anther example,




embedded image



can be phenyl.


In one aspect,




embedded image



can be one or more of:




embedded image



or a combination thereof. In one aspect, Rn can be C1-C3 alkyl. For example,




embedded image



can be




embedded image


In one aspect,




embedded image



can be present or absent. For example,




embedded image



can be absent. If present,




embedded image



can, in one aspect, be —O—.


In one aspect,




embedded image



can be present or absent For example,




embedded image



can be absent. In another example,




embedded image



can be —S—, —S(R1)2—, —C(R2)2—, —O—, —NH—or —NRn—. In one aspect, each R1 can individually be H or C1-C3 alkyl, for example C2 alkyl. In one aspect, each R2 can individually be H or C1-C3 alkyl, for example C1 alkyl. In one aspect, Rn can be C1-C3 alkyl. For example, Rn can be C2 alkyl.


In one aspect,




embedded image



can be present or absent. For example,




embedded image



can be absent. In another example,




embedded image



can be —S—,—S(R1)2—, —O—, —NH— or —NRn—. In one aspect, each R1 can individually be H or C1-C3 alkyl, for example C2 alkyl. In one aspect, Rn can be C1-C3 alkyl. For example, Rn can be C2 alkyl.


In one aspect, W can be Cl, nitrile, phenyl, naphthyl or isoquinoline; and




embedded image



can be isoquinoline, methylimidazole, or




embedded image



In another aspect, W can be Cl, nitrile, phenyl, naphthyl or isoquinoline;




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl. In another aspect, W can be Cl, nitrile, phenyl, naphthyl or isoquinoline;




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl; and




embedded image



can be pyridine. In another aspect, W can be Cl, nitrile, phenyl, naphthyl or isoquinoline;




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine;




embedded image



can be phenyl; and can




embedded image



can be absent. In another aspect, W can be Cl, nitrile, phenyl, naphthyl or isoquinoline;




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine;




embedded image



can be phenyl; and




embedded image



can be phenyl.


In another aspect, the compositions of the present invention can be represented by the general formula:




embedded image



wherein M represents platinum, palladium, or a combination thereof, wherein each of Ar1, Ar2, Ar3, and Ar4 independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; where each of X1, X2, X3 and X4 can individually be coordinated to a platinum and/or palladium atom, and can independently represent a carbon and/or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, wherein Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; wherein each of A1 and A2 can independently represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein each of A1 and A2 can independently optionally be substituted, wherein each of b1 and b2 can individually optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


In one aspect, M can be Pt, such as Pt(II). In another aspect, M can be Pd, such as Pd(II).


In one aspect,




embedded image



can be pyridine, quinazoline, isoquinoline, methylimidazole, or




embedded image


In one aspect,




embedded image



can be phenyl or pyridine.


In one aspect,




embedded image



can be phenyl or pyridine.


In one aspect,




embedded image



can be phenyl, pyridine, isoquinoline, naphthyl,




embedded image



For example,




embedded image



can be phenyl. In another example,




embedded image



can be pyridine. In another example,




embedded image



can be naphthyl or isoquinoline.


In one aspect,




embedded image



can be phenyl.


In one aspect,




embedded image



can be phenyl or absent. For example,




embedded image



can be absent. In anther example,




embedded image



can be phenyl.


In one aspect,




embedded image



can be




embedded image



or a combination thereof. In one aspect, Rn can be C1-C6 alkyl, such as C2 alkyl. For example,




embedded image



can be




embedded image


In one aspect,




embedded image



can be




embedded image



or a combination thereof. In one aspect, Rn can be C1-C6 alkyl, such as C2 alkyl. For example,




embedded image



can be




embedded image



In another aspect,




embedded image



can be —O—, if




embedded image



is absent.


In one aspect,




embedded image



can be present or absent. For example,




embedded image



can be absent. If present,




embedded image



can be —O—.


In one aspect,




embedded image



can be present or absent. For example,




embedded image



can be absent. In another example,




embedded image



can be —S—,—S(R1)2—, —C(R2)2—, —O—, —NH— or —NRR—. In one aspect, each R1 can individually be H or C1-C3 alkyl, for example C2 alkyl. In one aspect, each R2 can individually be H or C1-C3 alkyl, for example C1 alkyl. In one aspect, Rn can be C1-C3 alkyl. For example, Rn can be C2 alkyl.


In one aspect,




embedded image



can be pyridine, isoquinoline, methvlimidazole, or




embedded image



can be phenyl. In another aspect,




embedded image



can be pyridine, isoquinoline, methylimidazole, or




embedded image




embedded image



can be phenyl; and can be pyridine. In another aspect,




embedded image



can be pyridine, isoquinoline, methylimidazole, or




embedded image




embedded image



can be phenyl; and




embedded image



can be phenyl. In another aspect,




embedded image



can be pyridine, isoquinoline, methylimidazole, or




embedded image




embedded image



can be phenyl;




embedded image



can be pyridine or phenyl;




embedded image



can be phenyl; and




embedded image



can be phenyl or pyridine. In another aspect,




embedded image



can be pyridine, isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine or phenyl; and




embedded image



can be phenyl or pyridine;




embedded image



can be phenyl; and




embedded image



can be absent. In another aspect,




embedded image



can be pyridine, isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine or phenyl; and




embedded image



can be phenyl or pyridine;




embedded image



can be phenyl; and




embedded image



can be phenyl.


In yet another aspect, the compositions of the present invention can be represented by the general formula:




embedded image



wherein M represents platinum, palladium, or a combination thereof, wherein each of Ar1, Ar2, Ar3, and Ar4 independently represent an aromatic ring or heterocyclic group which can be substituted or unsubstituted; wherein each of X1, X2, X3 and X4 can individually be coordinated to the platinum and/or palladium atom, and can independently represent a carbon and/or a nitrogen atom, wherein Ar5 can represent an aromatic ring, a heterocyclic group, or a combination thereof, wherein Ar6 can represent an aromatic ring, a heterocyclic group, a combination thereof, or can be absent; wherein A1 can represent a linking atom, such as, for example, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof, and wherein A1 can optionally be substituted, wherein each b1, b2, and b3 can individually optionally be present or absent, and if present can independently represent oxygen, sulfur, nitrogen, carbon, boron, phosphorus, silicon, or a combination thereof.


In one aspect, M can be Pt, such as Pt(II). In another aspect, M can be Pd, such as Pd(II).


In one aspect,




embedded image



can be pyridine, quinazoline, isoquinoline, methylimidazole, or




embedded image


In one aspect,




embedded image



can be phenyl or pyridine.


In one aspect,




embedded image



can be phenyl or pyridine.


In one aspect,




embedded image



can be phenyl, pyridine, isoquinoline, naphthyl,




embedded image



For example,




embedded image



can be phenyl. In another example,




embedded image



can be pyridine. In another example,




embedded image



can be naphthyl or isoquinoline.


In one aspect,




embedded image



can be phenyl.


In one aspect,




embedded image



can be phenyl or absent. For example,




embedded image



can be absent. In anther example,




embedded image



can be phenyl.


In one aspect,




embedded image



can be




embedded image



or a combination thereof. In one aspect, Rn can be C1-C6 alkyl, such as C2 alkyl. For example,




embedded image



can be




embedded image


In one aspect,




embedded image



can be present or absent. For example,




embedded image



can be absent. If present,




embedded image



can be —O—.


In one aspect,




embedded image



can be present or absent. For example,




embedded image



can be absent. In another example,




embedded image



can be —S—,—S(R1)2—, —C(R2)2—, —O—, —NH— or —NRn—. In one aspect, each R1 can individually be H or C1-C3 alkyl, for example C2 alkyl. In one aspect, each R2 can individually be H or C1-C3 alkyl, for example C1 alkyl. In one aspect, Rn can be C1-C3 alkyl. For example, Rn can be C2 alkyl.


In one aspect,




embedded image



can be




embedded image



or a combination thereof. In one aspect, Rn can be C1-C6 alkyl, such as C2 alkyl. For example,




embedded image



can be




embedded image


In one aspect,




embedded image



can be pyridine, isoquinoline, methvlimidazole, or




embedded image



can be phenyl. In another aspect,




embedded image



can be isoquinoline, methylimidazole, or




embedded image




embedded image



can be phenyl; and




embedded image



can be pyridine. In another aspect,




embedded image



can be isoquinoline, methylimidazole, or




embedded image




embedded image



can be phenyl; and




embedded image



can be phenyl. In another aspect,




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine or phenyl; and




embedded image



can be phenyl or pyridine.


In another aspect,




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine or phenyl; and




embedded image



can be phenyl or pyridine;




embedded image



and can be absent. In another aspect,




embedded image



can be isoquinoline, methylimidazole, or




embedded image



can be phenyl;




embedded image



can be pyridine or phenyl; and




embedded image



can be phenyl or pyridine; and




embedded image



can be phenyl.


In one aspect, each of the above formulas




embedded image



can comprise one or more of the following:




embedded image


embedded image


embedded image



or a combination thereof. In one aspect, R1 can be H or C1-C3 alkyl. In one aspect, n can be 1 or 0. For example, n can be 0. In one aspect, R3 can be C1-C3 alkyl. In one aspect, U can be —C(R2)2, —O— or —S—. Each R2 can individually be H or C1-C3 alkyl.


In another aspect, each of the above formulas




embedded image



can each independently represent one or more of the following:




embedded image



or a combination thereof. In one aspect, m can be 1 or 0. In one aspect, R1 can be C1-C3 alkyl, for example C2 alkyl.


In another aspect, in all above formulas each




embedded image



can independently represent one or more of the following:




embedded image



or a combination thereof. In one aspect, Rn can be C1-C3 alkyl, such as C2 alkyl.


In another aspect, in all above formulas each




embedded image



can independently represent one or more of the following:




embedded image



or a combination thereof. Bn is a generic description of B1, B2 and/or B3. In one aspect, Rn can be C1-C3 alkyl, such as C2 alkyl. Bn can be present or absent.


In another aspect, in all above formulas




embedded image



can represent one or more of the following:




embedded image


embedded image



or a combination thereof. In one aspect, b can —O—, —S—, —N(R1)—, or —C(R1)2—. In one aspect, each R1 can individually be H or C1-C3 alkyl, such as C2 alkyl. For example, b can be —O—, —S—, or —N(C2H5)—.


In another aspect, in all above formulas each of




embedded image



each represent one or more of the following:




embedded image



or a combination thereof. For example,




embedded image



can individually be




embedded image


In another aspect, in all above formulas




embedded image



may be any one as following:




embedded image


embedded image


embedded image



In one aspect, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, can individually be H or C1-C3 alkyl, such as C2 alkyl. In one aspect, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, can individually be H. In one aspect, U can be —C(R2)2, —O— or —S—. Each R2 can individually be H or C1-C3 alkyl.


In other aspects, the inventive composition can comprise any one or more of the following specific examples:




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image



or a combination thereof.


It should be understood that the specific exemplary compositions recited herein are intended to be exemplary and not limiting. In another aspect, the present invention can exclude, or not include, any one or more of the compounds recited herein. For example, in one aspect, the present invention does not comprise the following complex:




embedded image


The inventive compositions of the present disclosure can be useful in a wide variety of applications, such as, for example, lighting devices. In a particular aspect, one or more of the complexes can be useful as an emitter for an organic light emitting display device.


The compounds of the invention are useful in a variety of applications. As light emitting materials, the compounds can be useful in organic light emitting diodes (OLEDs), luminescent devices and displays, and other light emitting devices, or as luminescent markers in bio-applications.


The emission (and absorption) profile of the compounds can be tuned by varying the structure of the ligand surrounding the metal center. For example, compounds having a ligand with electron withdrawing substituents will generally exhibit different optical properties, including emission and absorption, than compounds having a ligand with electron donating substituents. Generally, a chemical structural change affects the electronic structure of the compound, which thereby affects the absorption and emission of the compound. Thus, the compounds of the present invention can be tailored or tuned to a specific application that desires a particular emission or absorption characteristic.


In another aspect, the emission spectrum of any of the compositions of the present disclosure can be tuned to a desired and/or customized spectrum. In another aspect, the complexes disclosed herein can provide a narrow bandwidth, enabling their use in, for example, applications in which broad spectrum emitters are not suitable.


In one aspect, the excited state dynamics of the complex can be described by the scheme:




embedded image



where 3LC represents the energy of the ligand centered triplet state, 1MLCT represents the energy of the metal-to-ligand charge transfer singlet state, T1 represents the energy of the emissive triplet state, S0 represents the energy of the ground state, and ΔE represents the difference in energy between 1MLCT and 3LC.


In still another aspect, an expansion utilizing different emitting portions and linking groups should provide narrow emitting complexes covering a wide range of the visible spectrum. The emission energy of a certain complex can be tuned by modifying the ligand centered triplet state of the emitting fragment (3LC). This can be accomplished through changes in structure that modify the energy of the donating or accepting portion of the emitting fragment.


In another aspect, the nature of the 1MLCT transitions can be controlled by modifying the ancillary portion of the complex (L{circumflex over ( )}X), through changes in the cyclometalating portion, the linking portions, or both.


In one aspect, the inventive compositions are useful as emitters for full color display application. In such an aspect, the geometry of cyclometalating ligands can be rigid. This rigidity can allow for similar geometry between the ground and excited state, resulting in a narrow emission spectra dominated by the transition from the lowest vibrational level in the excited state to the lowest vibrational level in the ground state.


In another aspect, complexes can be designed to tune the values of the emitting fragment centered 3LC state and the metal to ancillary ligand 1MLCT states independently. Reduction in the differences in energy between these states (ΔE) will improve mixing between them, improve the radiative decay rate, and suppress transitions that occur from the emissive state (T1) to excited vibrational levels in the ground state (S0). As a consequence, the vibrational shoulders of the emission spectra can be reduced, resulting in a more narrow emission profile.


In a further aspect, the molecular structure having four coordinating ligands to a metal center can be preferred. In such an aspect, a four ligand coordinated structure can at least partially ensure the electrochemical and/or photophysical stability of the complex during, for example, fabrication and operation of a color display device.


In another aspect, the inventive compositions can provide improved efficiency and/or operational lifetimes in lighting devices, such as, for example, organic light emitting devices, such as OLEDs, as compared to conventional materials. Thus, also disclosed herein are devices comprising the complexes described herein. One application for phosphorescent emissive complexes, such as those described herein, is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Color may be measured using CIE coordinates, which are well known to the art.


In other various aspects, the inventive compositions can be useful as, for example, luminescent labels, emitters for organic light emitting diodes, lighting applications, and combinations thereof.


The compounds of the invention can be made using a variety of methods, including, but not limited to those recited in the examples provided herein. In other aspects, one of skill in the art, in possession of this disclosure, could readily determine an appropriate method for the preparation of an iridium complex as recited herein.


EXAMPLES

The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how the compounds, compositions, articles, devices and/or methods claimed herein are made and evaluated, and are intended to be purely exemplary of the invention and are not intended to limit the scope of what the inventors regard as their invention. Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.), but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in ° C. or is at ambient temperature, and pressure is at or near atmospheric.


Example 1



embedded image


4′-bromo-2-nitrobiphenyl: Under a nitrogen atmosphere, 20 mL of water was heated to 60° C. and 125 mmol of 2-nitrobyphenyl was added and stirred for 30 minutes before 6.3 mmol of iron trichloride was added and stirred for 30 minutes further. 140 mmol of bromine was added dropwise over 40 minutes and allowed to stir overnight before setting to reflux for 4 hours. After cooling, residual bromine was removed by washing with a sodium bisulfate solution. The organic residue was then washed twice with water, twice with concentrated sodium hydroxide, and then twice with water. The organic portion was separated and dissolved in dichloromethane before being dried with magnesium sulfate. The solution was concentrated under reduced pressure, subjected to flash column chromatography of silica with dichloromethane as the eluent, and concentrated again under reduced pressure. 4′-bromo-2-nitrobiphenyl was collected by recrystallization from methanol in 50% yield.




embedded image


2-bromo-9H-carbazole: Under a nitrogen atmosphere, 100 mmol of 4′-bromo-2-nitrobiphenyl was set to reflux overnight in stirring tirethylphosphite. After cooling, the triethylphosphite was distilled off and 2-bromo-9H-carbazole was isolated by recrystallization from methanol and further purified by train sublimation, resulting in a 65% yield.




embedded image


2-bromo-9-(pyridin-2-yl)-9H-carbazole: Under a nitrogen atmosphere, 10 mmol of 2-bromo-9H-carbazole, 15 mmol of 2-bromopyridine, 1 mmol of copper(I)iodide, 25 mmol of potassium carbonate, and 2 mmol of L-proline were combined in stirring degassed dimethyl sulfoxide. The mixture was heated to 90° C. for 3 days before being cooled and separated between dichloromethane and water. The water layer was washed twice with dichloromethane and the organics were combined and washed once with brine. The organic fraction was dried with magnesium sulfate and concentrated under reduced pressure and subjected to column chromatography of silica with dichloromethane as the eluent. After concentrating under reduced pressure, 2-bromo-9-(pyridin-2-yl)-9H-carbazole was isolated in a 70% yield.




embedded image


2-bromo-9-(tetrahydro-2H-pyran-2-yl)-9H-carbazole: 10 mmol of 2-bromo-9H-carbazole, 0.1 mmol of pyridinium toluene-4-sulphonate, and 50 mmol of 3,4-dihydro-2H-pyran was added to dichloromethane at room temperature and let stir for 2 hours before the temperature was raised to 50° C. for 2 hours further. The solution was cooled, concentrated under reduced pressure, and subjected to column chromatography of silica with dichloromethane as the eluent. After concentrating under reduced pressure, 2-bromo-9-(tetrahydro-2H-pyran-2-yl)-9H-carbazole was isolated in 90% yield.




embedded image


2-(1H-pyrazol-1-yl)-9-(tetrahydro-2H-pyran-2-yl)-9H-carbazole: Under a nitrogen atmosphere, 10 mmol of 2-bromo-9-(tetrahydro-2H-pyran-2-yl)-9H-carbazole, 15 mmol of pyrazole, 1 mmol of copper(I)iodide, 25 mmol of potassium carbonate, and 2 mmol of L-proline were combined in 25 mL of stirring degassed dimethyl sulfoxide. The mixture was heated to 90° C. for 3 days before being cooled and separated between dichloromethane and water. The water layer was washed twice with dichloromethane and the organics were combined and washed once with brine. The organic fraction was dried with magnesium sulfate and concentrated under reduced pressure and subjected to column chromatography of silica with dichloromethane as the eluent. After concentrating under reduced pressure, 2-(1H-pyrazol-1-yl)-9-(tetrahydro-2H-pyran-2-yl)-9H-carbazole was isolated in a 40% yield.




embedded image


2-(1H-pyrazol-1-yl)-9H-carbazole: 5 mmol of 2-(1H-pyrazol-1-yl)-9-(tetrahydro-2H-pyran-2-yl)-9H-carbazole was dissolved in 100 mL of methanol before 25 mmol of methylsulfonic acid was added slowly. The solution was stirred at room temperature for 2 hours, then at 50° C. for 2 hours further. The reaction was cooled, quenched with sodium bicarbonate, and separated between dichloromethane and water. The water was washed twice with dichloromethane, the organic fractions combined and washed once with brine. The organic fraction was then dried with magnesium sulfate, filtered, and the filtrate concentrated under reduced pressure. The resulting solid was subjected to column chromatography, using silica and dichloromethane/ethyl acetate as the eluent. After concentration under reduced pressure, 2-(1H-pyrazol-1-yl)-9H-carbazole was isolated in 90% yield.




embedded image


2′-(1H-pyrazol-1-yl)-9-(pyridin-2-yl)-9H-2,9′-bicarbazole: Under a nitrogen atmosphere, 10 mmol of 2-(1H-pyrazol-1-yl)-9H-carbazole, 10 mmol of 2-bromo-9-(pyridin-2-yl)-9H-carbazole, 1 mmol of copper(I)iodide, 25 mmol of potassium carbonate, and 2 mmol of L-proline were combined in stirring degassed dimethyl sulfoxide. The mixture was heated to 90° C. for 3 days before being cooled and separated between dichloromethane and water. The water layer was washed twice with dichloromethane and the organics were combined and washed once with brine. The organic fraction was dried with magnesium sulfate and concentrated under reduced pressure and subjected to column chromatography of silica with dichloromethane/ethyl acetate as the eluent. After concentrating under reduced pressure, 2′-(1H-pyrazol-1-yl)-9-(pyridin-2-yl)-9H-2,9′-bicarbazole was isolated in a 60% yield.




embedded image


[2′-(1H-pyrazol-1-yl)-9-(pyridin-2-yl)-9H-2,9′-bicarbazole]Pt(II), PtN1N: Under a nitrogen atmosphere, 10 mmol of 2′-(1H-pyrazol-1-yl)-9-(pyridin-2-yl)-9H-2,9′-bicarbazole, 9 mmol of K2PtCl4, and 4 Å molecular sieves were added to stirring acetic acid. The mixture was heated to 120° C. for 3 days. The solution was cooled, and poured into 100 mL of stirring dichloromethane. The mixture was filtered, and the filtrate concentrated under reduced pressure. The emissive solid was subjected to flash chromatography of silica with dichloromethane as the eluent.

Claims
  • 1. A composition represented by the general formula:
  • 2. The composition of claim 1, wherein
  • 3. The composition of claim 1, wherein
  • 4. The composition of claim 1, wherein each of
  • 5. The composition of claim 1, wherein
  • 6. The composition of claim 1, wherein W is Cl, F, C3 alkynyl, nitrile, quinazoline, isoquinoline, substituted or unsubstituted phenyl, or substituted or unsubstituted naphthyl.
  • 7. The composition of claim 1, wherein
  • 8. The composition of claim 1, wherein W is Cl, nitrile, phenyl, naphthyl or isoquinoline;
  • 9. The composition of claim 1, wherein
  • 10. The composition of claim 1, wherein b1 represents a single bond.
  • 11. The composition of claim 1, wherein b2 is —S—,—S(R1)2—, —C(R2)2—, —O—, —NH— or —NRn—; wherein each R1 and R2 is independently H or C1-C3 alkyl; andRn is C1-C3 alkyl.
  • 12. The composition of claim 1, wherein M comprises platinum(II).
  • 13. The composition of claim 1, wherein M comprises palladium(II).
  • 14. The composition of claim 1, comprising
  • 15. An organic light emitting device (OLED) comprising the compound of claim 1.
  • 16. A full color display comprising the OLED of claim 15.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/640,686, filed Jul. 3, 2017, now allowed, which is a continuation of U.S. patent application Ser. No. 14/996,522, filed Jan. 15, 2016, now U.S. Pat. No. 9,698,359, which is a divisional of U.S. patent application Ser. No. 13/479,921, filed May 24, 2012, now U.S. Pat. No. 9,238,668, which claims priority to U.S. Provisional Patent Application No. 61/490,111, filed May 26, 2011, all which are incorporated by reference herein in their entireties

STATEMENT OF GOVERNMENT SUPPORT

The present invention was made with financial support from the National Science Foundation under Career Grant No. 0748867. The U.S. government has certain rights in this invention.

US Referenced Citations (229)
Number Name Date Kind
4769292 Tang Sep 1988 A
5707745 Forrest Jan 1998 A
5844363 Gong Dec 1998 A
6303238 Thompson Oct 2001 B1
6780528 Tsuboyama Aug 2004 B2
7002013 Chi Feb 2006 B1
7037599 Culligan May 2006 B2
7064228 Yu Jun 2006 B1
7268485 Tyan Sep 2007 B2
7279704 Walters Oct 2007 B2
7332232 Ma Feb 2008 B2
7442797 Itoh Oct 2008 B2
7501190 Ise Mar 2009 B2
7655322 Forrest Feb 2010 B2
7854513 Quach Dec 2010 B2
7947383 Ise May 2011 B2
8106199 Jabbour Jan 2012 B2
8133597 Yasukawa Mar 2012 B2
8389725 Li Mar 2013 B2
8617723 Stoessel Dec 2013 B2
8669364 Li Mar 2014 B2
8816080 Li Aug 2014 B2
8846940 Li Sep 2014 B2
8871361 Xia Oct 2014 B2
8927713 Li Jan 2015 B2
8946417 Jian Feb 2015 B2
9059412 Zeng Jun 2015 B2
9076974 Li Jul 2015 B2
9082989 Li Jul 2015 B2
9203039 Li Dec 2015 B2
9221857 Li Dec 2015 B2
9224963 Li Dec 2015 B2
9238668 Li Jan 2016 B2
9312502 Li Apr 2016 B2
9312505 Brooks Apr 2016 B2
9318725 Li Apr 2016 B2
9324957 Li Apr 2016 B2
9382273 Li Jul 2016 B2
9385329 Li Jul 2016 B2
9425415 Li Aug 2016 B2
9502671 Li Nov 2016 B2
9550801 Li Jan 2017 B2
9598449 Li Mar 2017 B2
9617291 Li Apr 2017 B2
9673409 Li Jun 2017 B2
9698359 Li Jul 2017 B2
9711739 Li Jul 2017 B2
9711741 Li Jul 2017 B2
9711742 Li Jul 2017 B2
9755163 Li Sep 2017 B2
9818959 Li Nov 2017 B2
9865825 Li Jan 2018 B2
9879039 Li Jan 2018 B2
9882150 Li Jan 2018 B2
9899614 Li Feb 2018 B2
9920242 Li Mar 2018 B2
9923155 Li Mar 2018 B2
9941479 Li Apr 2018 B2
9947881 Li Apr 2018 B2
9985224 Li May 2018 B2
10020455 Li Jul 2018 B2
10033003 Li Jul 2018 B2
10056564 Li Aug 2018 B2
10056567 Li Aug 2018 B2
10158091 Li Dec 2018 B2
10177323 Li Jan 2019 B2
10211411 Li Feb 2019 B2
10211414 Li Feb 2019 B2
10263197 Li Apr 2019 B2
10294417 Li May 2019 B2
10392387 Li Aug 2019 B2
10411202 Li Sep 2019 B2
10414785 Li Sep 2019 B2
10516117 Li Dec 2019 B2
10566553 Li Feb 2020 B2
10566554 Li Feb 2020 B2
20010019782 Igarashi Sep 2001 A1
20020068190 Tsuboyama Jun 2002 A1
20030062519 Yamazaki Apr 2003 A1
20040230061 Seo Nov 2004 A1
20050170207 Ma Aug 2005 A1
20050260446 Mackenzie Nov 2005 A1
20060024522 Thompson Feb 2006 A1
20060073359 Ise Apr 2006 A1
20060094875 Itoh May 2006 A1
20060127696 Stossel Jun 2006 A1
20060182992 Nii Aug 2006 A1
20060202197 Nakayama Sep 2006 A1
20060210831 Sano Sep 2006 A1
20060255721 Igarashi Nov 2006 A1
20060263635 Ise Nov 2006 A1
20060286406 Igarashi Dec 2006 A1
20070057630 Nishita Mar 2007 A1
20070059551 Yamazaki Mar 2007 A1
20070082284 Stoessel Apr 2007 A1
20070103060 Itoh May 2007 A1
20080001530 Ise Jan 2008 A1
20080036373 Itoh Feb 2008 A1
20080054799 Satou Mar 2008 A1
20080079358 Satou Apr 2008 A1
20080111476 Choi May 2008 A1
20080241518 Satou Oct 2008 A1
20080241589 Fukunaga Oct 2008 A1
20080269491 Jabbour Oct 2008 A1
20090026936 Satou Jan 2009 A1
20090026939 Kinoshita Jan 2009 A1
20090032989 Karim Feb 2009 A1
20090039768 Igarashi Feb 2009 A1
20090079340 Kinoshita Mar 2009 A1
20090128008 Ise May 2009 A1
20090136779 Cheng May 2009 A1
20090218561 Kitamura Sep 2009 A1
20090261721 Murakami Oct 2009 A1
20090267500 Kinoshita Oct 2009 A1
20100000606 Thompson Jan 2010 A1
20100013386 Thompson Jan 2010 A1
20100141127 Xia Jun 2010 A1
20100171111 Takada Jul 2010 A1
20100171418 Kinoshita Jul 2010 A1
20100204467 Lamarque Aug 2010 A1
20100270540 Chung Oct 2010 A1
20100297522 Creeth Nov 2010 A1
20110028723 Li Feb 2011 A1
20110049496 Fukuzaki Mar 2011 A1
20110062858 Yersin Mar 2011 A1
20110301351 Li Dec 2011 A1
20120039323 Hirano Feb 2012 A1
20120095232 Li Apr 2012 A1
20120108806 Li May 2012 A1
20120181528 Takada Jul 2012 A1
20120199823 Molt Aug 2012 A1
20120202997 Parham Aug 2012 A1
20120215001 Li Aug 2012 A1
20120223634 Xia Sep 2012 A1
20120264938 Li Oct 2012 A1
20120273736 James Nov 2012 A1
20120302753 Li Nov 2012 A1
20130048963 Beers Feb 2013 A1
20130137870 Li May 2013 A1
20130168656 Tsai Jul 2013 A1
20130203996 Li Aug 2013 A1
20130237706 Li Sep 2013 A1
20130341600 Lin Dec 2013 A1
20140014922 Lin Jan 2014 A1
20140027733 Zeng Jan 2014 A1
20140066628 Li Mar 2014 A1
20140073798 Li Mar 2014 A1
20140084261 Brooks Mar 2014 A1
20140114072 Li Apr 2014 A1
20140147996 Vogt May 2014 A1
20140148594 Li May 2014 A1
20140191206 Cho Jul 2014 A1
20140203248 Zhou Jul 2014 A1
20140249310 Li Sep 2014 A1
20140326960 Kim Nov 2014 A1
20140330019 Li Nov 2014 A1
20140364605 Li Dec 2014 A1
20150008419 Li Jan 2015 A1
20150018558 Li Jan 2015 A1
20150028323 Xia Jan 2015 A1
20150069334 Xia Mar 2015 A1
20150105556 Li Apr 2015 A1
20150162552 Li Jun 2015 A1
20150194616 Li Jul 2015 A1
20150207086 Li Jul 2015 A1
20150228914 Li Aug 2015 A1
20150274762 Li Oct 2015 A1
20150287938 Li Oct 2015 A1
20150311456 Li Oct 2015 A1
20150318500 Li Nov 2015 A1
20150349279 Li Dec 2015 A1
20160028028 Li Jan 2016 A1
20160028029 Li Jan 2016 A1
20160043331 Li Feb 2016 A1
20160133861 Li May 2016 A1
20160133862 Li May 2016 A1
20160194344 Li Jul 2016 A1
20160197285 Zeng Jul 2016 A1
20160197291 Li Jul 2016 A1
20160285015 Li Sep 2016 A1
20160359120 Li Dec 2016 A1
20160359125 Li Dec 2016 A1
20170005278 Li Jan 2017 A1
20170012224 Li Jan 2017 A1
20170040555 Li Feb 2017 A1
20170047533 Li Feb 2017 A1
20170066792 Li Mar 2017 A1
20170069855 Li Mar 2017 A1
20170077420 Li Mar 2017 A1
20170125708 Li May 2017 A1
20170267923 Li Sep 2017 A1
20170271611 Li Sep 2017 A1
20170301871 Li Oct 2017 A1
20170305881 Li Oct 2017 A1
20170331056 Li Nov 2017 A1
20170342098 Li Nov 2017 A1
20170373260 Li Dec 2017 A1
20180006246 Li Jan 2018 A1
20180053904 Li Feb 2018 A1
20180130960 Li May 2018 A1
20180138428 Li May 2018 A1
20180148464 Li May 2018 A1
20180159051 Li Jun 2018 A1
20180166655 Li Jun 2018 A1
20180175329 Li Jun 2018 A1
20180194790 Li Jul 2018 A1
20180219161 Li Aug 2018 A1
20180226592 Li Aug 2018 A1
20180226593 Li Aug 2018 A1
20180277777 Li Sep 2018 A1
20180301641 Li Oct 2018 A1
20180312750 Li Nov 2018 A1
20180331307 Li Nov 2018 A1
20180334459 Li Nov 2018 A1
20180337345 Li Nov 2018 A1
20180337349 Li Nov 2018 A1
20180337350 Li Nov 2018 A1
20190013485 Li Jan 2019 A1
20190067602 Li Feb 2019 A1
20190109288 Li Apr 2019 A1
20190194536 Li Jun 2019 A1
20190259963 Li Aug 2019 A1
20190276485 Li Sep 2019 A1
20190312217 Li Oct 2019 A1
20190367546 Li Dec 2019 A1
20190389893 Li Dec 2019 A1
20200006678 Li Jan 2020 A1
20200071330 Li Mar 2020 A1
20200075868 Li Mar 2020 A1
Foreign Referenced Citations (152)
Number Date Country
1680366 Oct 2005 CN
1777663 May 2006 CN
1894269 Jan 2007 CN
101142223 Mar 2008 CN
101667626 Mar 2010 CN
102449108 May 2012 CN
102892860 Jan 2013 CN
102971396 Mar 2013 CN
103102372 May 2013 CN
104232076 Dec 2014 CN
104377231 Feb 2015 CN
104693243 Jun 2015 CN
105367605 Mar 2016 CN
105418591 Mar 2016 CN
1808052 Jul 2007 EP
1874893 Jan 2008 EP
1874894 Jan 2008 EP
1919928 May 2008 EP
2036907 Mar 2009 EP
2096690 Sep 2009 EP
2112213 Oct 2009 EP
2417217 Feb 2012 EP
2711999 Mar 2014 EP
2002105055 Apr 2002 JP
2005267557 Sep 2005 JP
2005310733 Nov 2005 JP
2006047240 Feb 2006 JP
2006232784 Sep 2006 JP
2006242080 Sep 2006 JP
2006242081 Sep 2006 JP
2006256999 Sep 2006 JP
2006257238 Sep 2006 JP
2006261623 Sep 2006 JP
2006290988 Oct 2006 JP
2006313796 Nov 2006 JP
2006332622 Dec 2006 JP
2006351638 Dec 2006 JP
2007019462 Jan 2007 JP
2007031678 Feb 2007 JP
2007042875 Feb 2007 JP
2007053132 Mar 2007 JP
2007066581 Mar 2007 JP
2007073620 Mar 2007 JP
2007073845 Mar 2007 JP
2007073900 Mar 2007 JP
2007080593 Mar 2007 JP
2007080677 Mar 2007 JP
2007088105 Apr 2007 JP
2007088164 Apr 2007 JP
2007096259 Apr 2007 JP
2007099765 Apr 2007 JP
2007110067 Apr 2007 JP
2007110102 Apr 2007 JP
2007258550 Oct 2007 JP
2007324309 Dec 2007 JP
2008010353 Jan 2008 JP
2008091860 Apr 2008 JP
2008103535 May 2008 JP
2008108617 May 2008 JP
2008109085 May 2008 JP
2008109103 May 2008 JP
2008160087 Jul 2008 JP
2008198801 Aug 2008 JP
2008270729 Nov 2008 JP
2008270736 Nov 2008 JP
2009016184 Jan 2009 JP
2009016579 Jan 2009 JP
2009032977 Feb 2009 JP
2009032988 Feb 2009 JP
2009076509 Apr 2009 JP
2009266943 Nov 2009 JP
2009267171 Nov 2009 JP
2009267244 Nov 2009 JP
2009272339 Nov 2009 JP
2009283891 Dec 2009 JP
2010135689 Jun 2010 JP
5604505 Sep 2012 JP
2012522843 Sep 2012 JP
2012207231 Oct 2012 JP
2012222255 Nov 2012 JP
2013053149 Mar 2013 JP
2013525436 Jun 2013 JP
2014221807 Nov 2014 JP
2015081257 Apr 2015 JP
20060115371 Nov 2006 KR
20070061830 Jun 2007 KR
20070112465 Nov 2007 KR
20130043460 Apr 2013 KR
101338250 Dec 2013 KR
200701835 Jan 2007 TW
201307365 Feb 2013 TW
0070655 Nov 2000 WO
2004003108 Jan 2004 WO
2004085450 Oct 2004 WO
2004108857 Dec 2004 WO
2005042444 May 2005 WO
2005042550 May 2005 WO
2005113704 Dec 2005 WO
2006033440 Mar 2006 WO
2006067074 Jun 2006 WO
2006098505 Sep 2006 WO
2006113106 Oct 2006 WO
2006115299 Nov 2006 WO
2006115301 Nov 2006 WO
2007034985 Mar 2007 WO
2007069498 Jun 2007 WO
2008054578 May 2008 WO
2008066192 Jun 2008 WO
2008066195 Jun 2008 WO
2008066196 Jun 2008 WO
2008101842 Aug 2008 WO
2008117889 Oct 2008 WO
2008123540 Oct 2008 WO
2009017211 Feb 2009 WO
2009023667 Feb 2009 WO
2009086209 Jul 2009 WO
2009111299 Sep 2009 WO
2010007098 Jan 2010 WO
2010056669 May 2010 WO
2010093176 Aug 2010 WO
2010105141 Sep 2010 WO
2010118026 Oct 2010 WO
2011064335 Jun 2011 WO
2011070989 Jun 2011 WO
2011089163 Jul 2011 WO
2011137429 Nov 2011 WO
2011137431 Nov 2011 WO
2012074909 Jun 2012 WO
2012112853 Aug 2012 WO
2012116231 Aug 2012 WO
2012142387 Oct 2012 WO
2012162488 Nov 2012 WO
2012163471 Dec 2012 WO
2013130483 Sep 2013 WO
2014016611 Jan 2014 WO
2014031977 Feb 2014 WO
2014047616 Mar 2014 WO
2014109814 Jul 2014 WO
2014208271 Dec 2014 WO
2015027060 Feb 2015 WO
2015131158 Sep 2015 WO
2016025921 Feb 2016 WO
2016029137 Feb 2016 WO
2016029186 Feb 2016 WO
2016197019 Dec 2016 WO
2018071697 Apr 2018 WO
2018140765 Aug 2018 WO
2019079505 Apr 2019 WO
2019079508 Apr 2019 WO
2019079509 Apr 2019 WO
2019236541 Dec 2019 WO
2020018476 Jan 2020 WO
Non-Patent Literature Citations (67)
Entry
Veezu, D et al.: Highly luminescent tridentate platinum complexes featured in fused five-six-membered metallocycle and diminishing quenching. Inorganic Chern., vol. 50 (17), pp. 8261-8273, 2011.
Ayan Maity et al., “Room-temperature synthesis of cyclometalated iridium(III) complexes; kinetic isomers and reactive functionalities” Chem. Sci., vol. 4, pp. 1175-1181 (2013).
Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, Sep. 10, 1998, pp. 151-154.
Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Applied Physics Letters, vol. 75, No. 1, Jul. 5, 1999, pp. 4-6.
Barry O'Brien et al.: White organic light emitting diodes using Pt-based red, green and blue phosphorescent dopants. Proc. SPIE, vol. 8829, pp. 1-6, Aug. 25, 2013.
Barry O'Brien et al., “High efficiency white organic light emitting diodes employing blue and red platinum emitters,” Journal of Photonics for Energy, vol. 4, 2014, p. 043597-1-8.
Brian W. D'Andrade et al., “Controlling Exciton Diffusion in Multilayer White Phosphorescent Organic Light Emitting Devices”, Adv. Mater., vol. 14, No. 2, Jan. 16, 2002, pp. 147-151.
Chew, S. et al.: Photoluminescence and electroluminescence of a new blue-emitting homoleptic iridium complex. Applied Phys. Letters; vol. 88, p. 093510-1-093510-3, 2006.
Chi et al.; Transition-metal phosphors with cyclometalating ligands: fundamentals and applications, Chemical Society Reviews, vol. 39, No. 2, Feb. 2010, pp. 638-655.
Chi-Ming Che et al. “Photophysical Properties and OLEO Applications of Phosphorescent Platinum(II) Schiff Base Complexes,” Chem. Eur. J., vol. 16, 2010, pp. 233-247.
Christoph Ulbricht et al., “Synthesis and Characterization of Oxetane-Functionalized Phosphorescent Ir(III)-Complexes”, Macromol. Chem. Phys. 2009, 210, pp. 531-541.
D.F. O'Brien et al., “Improved energy transfer in electrophosphorescent devices,” Appl. Phys. Lett., vol. 74, No. 3, Jan. 18, 1999, pp. 442-444.
Dan Wang et al., “Carbazole and arylamine functionalized iridium complexes for efficient electro-phosphorescent light-emitting diodes”, Inorganica Chimica Acta 370 (2011) pp. 340-345.
Dileep A. K. Vezzu et al., “Highly Luminescent Tetradentate Bis-Cyclometalated Platinum Complexes: Design, Synthesis, Structure, Photophysics, and Electroluminescence Application,” Inorg. Chem., vol. 49, 2010, pp. 5107-5119.
Dorwald; “Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design,” Chapter 1, 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Wienheim, 32 pages.
Eric Turner et al., “Cyclometalated Platinum Complexes with Luminescent Quantum Yields Approaching 100%,” Inorg. Chem., 2013, vol. 52, pp. 7344-7351.
Evan L. Williams et al., “Excimer-Based White Phosphorescent Organic Light Emitting Diodes with Nearly 100% Internal Quantum Efficiency,” Adv. Mater., vol. 19, 2007, pp. 197-202.
Glauco Ponterini et al., “Comparison of Radiationless Decay Processes in Osmium and Platinum Porphyrins,” J. Am. Chern. Soc., vol. 105, No. 14, 1983, pp. 4639-4645.
Guijie Li et al., “Efficient and stable red organic light emitting devices from a tetradentate cyclometalated platinum complex,” Organic Electronics, 2014, vol. 15 pp. 1862-1867.
Guijie Li et al., “Modifying Emission Spectral Bandwidth of Phosphorescent Platinum(II) Complexes Through Synthetic Control,” Inorg. Chern. 2017, 56, 8244-8256.
Guijie Li et al., Efficient and Stable White Organic Light-Emitting Diodes Employing a Single Emitter, Adv. Mater., 2014, vol. 26, pp. 2931-2936.
Hirohiko Fukagawa et al., “Highly Efficient and Stable Red Phosphorescent Organic Light-Emitting Diodes Using Platinum Complexes,” Adv. Mater., 2012, vol. 24, pp. 5099-5103.
Hoe-Joo Seo et al., “Blue phosphorescent iridium(III) complexes containing carbazole-functionalized phenyl pyridine for organic light-emitting diodes: energy transfer from carbazolyl moieties to iridium(III) cores”, RSC Advances, 2011, 1, pp. 755-757.
Huaijun Tang et al., “Novel yellow phosphorescent iridium complexes containing a carbazoleeoxadiazole unit used in polymeric light-emitting diodes”, Dyes and Pigments 91 (2011) pp. 413-421.
Ivaylo Ivanov et al., “Comparison of the INDO band structures of polyacetylene, polythiophene, polyfuran, and polypyrrole,” Synthetic Metals, vol. 116, Issues 1-3, Jan. 1, 2001, pp. 111-114.
Jack W. Levell et al., “Carbazole/iridium dendrimer side-chain phosphorescent copolymers for efficient light emitting devices”, New J. Chern., 2012, vol. 36, pp. 407-413.
Jan Kalinowski et al., “Light-emitting devices based on organometallic platinum complexes as emitters,” Coordination Chemistry Reviews, vol. 255, 2011, pp. 2401-2425.
Jeonghun Kwak et al., “Bright and Efficient Full-Color Colloidal Quantum Dot Light-Emitting Diodes Using an Inverted Device Structure,” Nano Letters 12, Apr. 2, 2012, pp. 2362-2366.
Ji Hyun Seo et al., “Efficient blue-green organic light-emitting diodes based on heteroleptic tris-cyclometalated iridium (III) complexes”. Thin Solid Films, vol. 517, pp. 1807-1810 (2009).
JP2009267244, English Translation from EPO, Nov. 2009, 80 pages.
JP2010135689, English translation from EPO, dated Jun. 2010, 95 pages.
Kai Li et al., “Light-emitting platinum(II) complexes supported by tetradentate dianionic bis(N-heterocyclic carbene) ligands: towards robust blue electrophosphors,” Chem. Sci., 2013, vol. 4, pp. 2630-2644.
Ke Feng et al., “Norbornene-Based Copolymers Containing Platinum Complexes and Bis(carbazolyl)benzene Groups in Their Side-Chains,” Macromolecules, vol. 42, 2009, pp. 6855-6864.
Kwon-Hyeon Kim et al., “Controlling Emitting Dipole Orientation with Methyl Substituents on Main Ligand of Iridium Complexes for Highly Efficient Phosphorescent Organic Light-Emitting Diodes”, Adv. Optical Mater. 2015, 3, pp. 1191-1196.
Kwon-Hyeon Kim et al., “Crystal Organic Light-Emitting Diodes with Perfectly Oriented Non-Doped Pt-Based Emitting Layer”, Adv. Mater. 2016, 28, pp. 2526-2532.
Maestri et al., “Absorption Spectra and Luminescence Properties of Isomeric Platinum (II) and Palladium (II) Complexes Containing 1,1′-Biphenyldiyl, 2-Phenylpyridine, and 2,2′-Bipyridine as Ligands,” Helvetica Chimica Acta, vol. 71, Issue 5, Aug. 10, 1988, pp. 1053-1059.
Marc Lepeltier et al., “Efficient blue green organic light-emitting devices based on a monofluorinated heteroleptic iridium(III) complex,” Synthetic Metals, vol. 199, 2015, pp. 139-146.
Matthew J. Jurow et al., “Understanding and predicting the orientation of heteroleptic phosphors in organic light-emitting materials”, Nature Materials, vol. 15, Jan. 2016, pp. 85-93.
Murakami; JP 2007324309, English machine translation from EPO, dated Dec. 13, 2007, 89 pages.
Nicholas R. Evans et al., “Triplet Energy Back Transfer in Conjugated Polymers with Pendant Phosphorescent Iridium Complexes,” J. Am. Chern. Soc., vol. 128, 2006, pp. 6647-6656.
Russell J. Holmes et al., “Blue and Near-UV Phosphorescence from Iridium Complexes with Cyclometalated Pyrazolyl or N-Heterocyclic Carbene Ligands,” Inorganic Chemistry, 2005, vol. 44, No. 22, pp. 7995-8003.
Satake et al., “Interconvertible Cationic and Neutral Pyridinylimidazole η3-Allylpalladium Complexes. Structural Assignment by 1H, 13C, and 15N NMR and X-ray Diffraction”, Organometallics, vol. 18, No. 24, 1999, pp. 5108-5111.
Shih-Chun Lo et al. “High-Triplet-Energy Dendrons: Enhancing the Luminescence of Deep Blue Phosphorescent Indium(III) Complexes” J. Am. Chern. Soc.,vol. 131, 2009, p. 16681-16688.
Shiro Koseki et al., “Spin-orbit coupling analyses of the geometrical effects on phosphorescence in Ir(ppy)3 and its derivatives”, J. Phys. Chern. C, vol. 117, pp. 5314-5327 (2013).
Shizuo Tokito et al. “Confinement of triplet energy on phosphorescent molecules for highly-efficient organic blue-light-emitting devices” Applied Physics Letters, vol. 83, No. 3, Jul. 21, 2003, pp. 569-571.
Stefan Bernhard, “The First Six Years: A Report,” Department of Chemistry, Princeton University, May 2008, 11 pages.
Stephen R. Forrest, “The path to ubiquitous and low-cost organic electronic appliances on plastic,” Nature, vol. 428, Apr. 29, 2004, pp. 911-918.
Steven C. F. Kui et al., “Robust phosphorescent platinum(II) complexes with tetradentate O∧N∧C∧N ligands: high efficiency OLEDs with excellent efficiency stability,” Chern. Commun., 2013, vol. 49, pp. 1497-1499.
Steven C. F. Kui et al., “Robust Phosphorescent Platinum(II) Complexes Containing Tetradentate O∧N∧C∧N Ligands: Excimeric Excited State and Application in Organic White-Light-Emitting Diodes,” Chem. Eur. J., 2013, vol. 19, pp. 69-73.
Supporting Information: Xiao-Chun Hang et al., “Highly Efficient Blue-Emitting Cyclometalated Platinum(II) Complexes by Judicious Molecular Design,” Wiley-VCH 2013, 7 pages.
Sylvia Bettington et al. “Tris-Cyclometalated Iridium(III) Complexes of Carbazole(fluorenyl)pyridine Ligands: Synthesis, Redox and Photophysical Properties, and Electrophosphorescent Light-Emitting Diodes” Chemistry: A European Journal, 2007, vol. 13, pp. 1423-1431.
Tyler Fleetham et al., “Efficient “pure” blue OLEDs employing tetradentate Pt complexes with a narrow spectral bandwidth,” Advanced Materials (Weinheim, Germany), Vo. 26, No. 41, 2014, pp. 7116-7121.
Tyler Fleetham et al., “Efficient Red-Emitting Platinum Complex with Long Operational Stability,” ACS Appl. Mater. Interfaces 2015, 7, 16240-16246.
U.S. Appl. No. 16/751,561, filed Jan. 24, 2020, has not yet published. Inventor: Li.
U.S. Appl. No. 16/751,586, filed Jan. 24, 2020, has not yet published. Inventor: Li et al.
V. Adamovich et al., “High efficiency single dopant white electrophosphorescent light emitting diodes”, New J. Chem, vol. 26, pp. 1171-1178. 2002.
Vanessa Wood et al., “Colloidal quantum dot light-emitting devices,” Nano Reviews 1, Jul. 2010, p. 5202. (7 pages).
Wong. Challenges in organometallic research—Great opportunity for solar cells and OLEDs. Journal of Organometallic Chemistry 2009, vol. 694, pp. 2644-2647.
Written Opinion dated Aug. 17, 2012 for Intl. Pat. App. No. PCT/US2012/039323 filed May 24, 2012 and published as WO 2012/162488 dated Nov. 29, 2012 (Applicants—Arizona Board of Regents Acting for and on Behalf of Arizona State University; Inventors—Li et al.; (6 pages).
Xiao-Chu Hang et al., “Highly Efficient Blue-Emitting Cyclometalated Platinum(II) Complexes by Judicious Molecular Design,” Angewandte Chemie, International Edition, vol. 52, Issue 26, Jun. 24, 2013, pp. 6753-6756.
Xiaofan Ren et al., “Ultrahigh Energy Gap Hosts in Deep Blue Organic Electrophosphorescent Devices,” Chern. Mater., vol. 16, 2004, pp. 4743-4747.
Xin Li et al., “Density functional theory study of photophysical properties of iridium (III) complexes with phenylisoquinoline and phenylpyridine ligands”, The Journal of Physical Chemistry C, 2011, vol. 115, No. 42, p. 20722-20731.
Ying Yang et al., “Induction of Circularly Polarized Electroluminescence from an Achiral Light-Emitting Polymer via a Chiral Small-Molecule Dopant,” Advanced Materials, vol. 25, Issue 18, May 14, 2013, pp. 2624-2628.
Z Liu et al., “Green and blue-green phosphorescent heteroleptic iridium complexes containing carbazole-functionalized beta-diketonate for non-doped organic light-emitting diodes”, Organic Electronics 9 (2008) pp. 171-182.
Z Xu et al., “Synthesis and properties of iridium complexes based 1,3,4-oxadiazoles derivatives”, Tetrahedron 64 (2008) pp. 1860-1867.
Zhi-Qiang Zhu et al., “Efficient Cyclometalated Platinum(II) Complex with Superior Operational Stability,” Adv. Mater. 29 (2017) 1605002, pp. 1-5.
Zhi-Qiang Zhu et.aL, “Harvesting All Electrogenerated Excitons through Metal Assisted Delayed Fluorescent Materials,” Adv. Mater. 27 (2015) 2533-2537.
Related Publications (1)
Number Date Country
20200403167 A1 Dec 2020 US
Provisional Applications (1)
Number Date Country
61490111 May 2011 US
Divisions (1)
Number Date Country
Parent 13479921 May 2012 US
Child 14996522 US
Continuations (2)
Number Date Country
Parent 15640686 Jul 2017 US
Child 17008762 US
Parent 14996522 Jan 2016 US
Child 15640686 US